Found 6 matching trials
Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A PHASE4 The purpose of this study is to determine the immunologic and overall safet...
Show More Location
Oddzial Chorob Wewnetrznych i Hematologii
Learn More & Join Trial
Alphanate in Immune Tolerance Induction Therapy PHASE2 This is a multicenter, multinational, prospective, single-arm, nonrandomize...
Show More Learn More & Join Trial
Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) NA The purpose of this study is to evaluate whether a concentrate containing b...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive NA This is a prospective, controlled, randomized, open label study, aimed at c...
Show More Location
Multiple Locations
Learn More & Join Trial
Survey of Inhibitors in Plasma-Product Exposed Toddlers PHASE4 The primary objective of the study is to assess the immunogenicity of VWF/F...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients PHASE4 To assess the efficacy of FVIII/VWF Complex (Human), Alphanate® as replacem...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial